Sputnik Light produces strong level of antibodies against COVID-19: early-stage trial

Russia's one-dose Sputnik Light vaccine had a good safety profile and induced strong immune responses especially in people who had already encountered COVID-19, according to the results of phase I and II trials published in The Lancet Regional Health - Europe medical journal.

from bdnews24.com - Home https://ift.tt/3ocxaxo